Condition

Psoriatic Arthritis (PsA) clinical trials and research

• 16Clinical trials
• 11Countries

Newest Psoriatic Arthritis (PsA) clinical trials

All recruiting trials (16)

• Carotid ultrasound to guide prevention of heart disease in inflammatory rheumatic diseases

  In people with inflammatory rheumatic diseases like RA, PsA, AxSpA, or SLE who are at modest cardiovascular risk, a carotid ultrasound test is used to see if they should start stronger lipid-lowering therapy to prevent heart problems.

  Recruiting at 7 sites Phase 4 Instituto de Investigación Marqués de Valdecilla · Alicante, Alicante and 16 other locations · NCT07611747

• Oxidative stress in autoimmune joint diseases

  Researchers will see if oxidative stress and antioxidant markers differ in adults with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.

  Recruiting University of Thessaly · Larissa, Thessaly · NCT07536529

• Preventing early joint damage in people with recent-onset psoriatic arthritis

  This trial tests whether a TNF blocker (an adalimumab biosimilar) works better than injected methotrexate at preventing early joint damage in adults who recently developed psoriatic arthritis.

  Recruiting Phase 4 Chinese University of Hong Kong · Hong Kong · NCT07486843

• Self-management app to help people with inflammatory arthritis stay safe

  A smartphone app from the French Rheumatology Society is being tested to help adults with rheumatoid arthritis or spondyloarthritis manage their treatments and safety while starting a new DMARD.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT07460739

• S-4321 in adults with autoimmune or immune-mediated diseases

  This study tests S-4321 in adults with autoimmune conditions to see if it is safe and tolerable and to gather early data on how the drug behaves in the body and its initial effects on disease markers.

  Recruiting at 2 sites Phase 1 Seismic Therapeutic AU Pty Ltd · Charlestown, New South Wales and 1 other locations · NCT07455578

• Combining the biologic ixekizumab with the weight-loss drug tirzepatide for people with psoriatic arthritis and overweight/obesity

  This trial will test whether ixekizumab, tirzepatide (a weight-loss drug), or both together change skin, joint, and fat tissue in adults with psoriatic arthritis who are overweight or obese.

  Recruiting NHS Greater Glasgow and Clyde · Birmingham, England and 3 other locations · NCT07443956

• Doctor screening versus questionnaire screening for psoriatic arthritis in people with psoriasis

  This study will test whether screening by a doctor or using short questionnaires finds more cases of psoriatic arthritis in adults with psoriasis.

  Recruiting Charite University, Berlin, Germany · Toronto, Ontario · NCT07298265

• Deucravacitinib added to current PsA treatment for difficult-to-control disease

  This study tests whether adding deucravacitinib to a patient’s existing Psoriatic Arthritis treatment can improve symptoms and quality of life for adults with hard-to-control disease.

  Recruiting Phase 4 University of Texas Southwestern Medical Center · Dallas, Texas · NCT07280702

• Comparing five advanced treatments for axial spondyloarthritis and psoriatic arthritis

  This project will see how well bimekizumab, risankizumab, guselkumab, upadacitinib, or a TNF inhibitor work for adults with axSpA or PsA who have just started one of these medicines, using medical records and patient surveys.

  Recruiting Adelphi Real World · Bath, Somerset · NCT07166315

• Lowering JAK inhibitor doses in people with RA, PsA, or axSpA who are in low disease activity or remission

  This study will test whether carefully lowering the dose of Janus kinase inhibitors keeps disease control as well as staying on the same dose in people with rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who are in remission or have low disease activity.

  Recruiting Phase 4 Sint Maartenskliniek · Nijmegen, Gelderland and 6 other locations · NCT07160231

• Personalized lab test to predict the best treatment for rheumatic diseases

  This project tests a lab-based cell assay to see if it can predict which DMARD will work best for adults with autoimmune rheumatic diseases such as RA, PsA, axSpA, and GCA.

  Recruiting University of Bonn · Bonn, North Rhine-Westphalia · NCT07150000

• GLP-1 drugs vs. nutrition counseling for Psoriatic Arthritis with obesity and diabetes

  This trial compares GLP-1 medications to nutrition counseling to see which approach best helps adults with psoriatic arthritis who also have obesity and type 2 diabetes.

  Recruiting Phase 4 Medical College of Wisconsin · Milwaukee, Wisconsin · NCT07111494

• Butantan live tetravalent dengue vaccine for people with autoimmune rheumatic diseases

  This study will test whether a single dose of the Butantan live tetravalent dengue vaccine is safe and produces immune responses in clinically stable people aged 12–59 with autoimmune rheumatic diseases compared with matched healthy volunteers.

  Recruiting at 2 sites Phase 4 University of Sao Paulo General Hospital · São Paulo, São Paulo and 1 other locations · NCT07087912

• Investigating the Role of Y Chromosome Mutations in Autoimmune Diseases

  This study is trying to see how changes in the Y chromosome might affect the immune system and contribute to autoimmune diseases like Giant Cell Arteritis and Polymyalgia Rheumatica.

  Recruiting University of Bonn · Bonn, North Rhine-Westphalia · NCT06696027

• A platform for collecting health data on ME/CFS and Long Covid

  This study is trying to collect health information from adults with ME/CFS and Long Covid to help researchers better understand these conditions and improve future treatments.

  Recruiting Brain Inflammation Collaborative · Delafield, Wisconsin · NCT04806620

• Cohort for patients with psoriatic arthritis

  This study is tracking 425 patients with their first signs of psoriatic arthritis over 10 years to see what factors lead to more severe disease and how to improve early treatment.

  Recruiting at 3 sites Assistance Publique - Hôpitaux de Paris · Créteil and 2 other locations · NCT03768271

Related topics

Quick answers

How many Psoriatic Arthritis (PsA) clinical trials are recruiting right now?

16, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 11 countries. The most sites are in United States (3 trials), United Kingdom (2 trials), France (2 trials), Germany (2 trials), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 6, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →